Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Sponsored by:

ELOS Medtech SurgeonPodLogo

  Surgeon Pod
      Wednesday, June 12 and Thursday, June 13


Follow the yellow floor stickers to the popular and powerful Surgeon Pod!

OMTEC's surgeon speakers possess deep engineering, entrepreneurial and "get it done" backgrounds. Each surgeon will deliver a 15-minute presentation and then invite and encourage Q&A and open discussion. 
These interactive and intimate conversations will help you generate development ideas and make you smarter about today's and tomorrow's challenges. The Surgeon Pod experience is ideal for engineers and regulatory staff seeking opportunities to speak one-on-one with surgeons...or anyone interested in future technologies and growing their network of surgeon and entrepreneurial minded professionals.

Wednesday, June 12

The Future of Artificial Intelligence and Augmented Reality in Orthopedics
10:00 am – 10:45 am

Artificial intelligence (AI) and augmented reality (AR) will revolutionize surgical navigation and robotic technologies. Through intelligent computer guidance (AI) and enhanced visualization (AR), surgeons will be able to utilize real-time image overlays displayed directly onto the operative field, allowing them to make smarter decisions. Kris B. Siemionow, M.D., Ph.D., and his company HoloSurgical have already performed spine surgeries with AI and AR technology, which he describes as the driverless Tesla of orthopedics. Dr. Siemionow will share why AI and AR should be adopted and ways that the technology can be integrated into today’s computer-assisted platforms.


  • Understand how AI and AR are being utilized in the operating room today
  • Gain knowledge of future AI and AR applications

Kris B. Siemionow, M.D., Ph.D.,
is Chief of Spine Surgery and Associate Professor of Orthopaedics and Neurosurgery at the University of Illinois in Chicago. Dr. Siemionow completed a residency in orthopedic surgery at the Cleveland Clinic in Cleveland, Ohio, fellowship training in Adult Spine Surgery at Rush University Medical Center and a pediatric spine fellowship at the Shriners Hospital for Children. Dr. Siemionow is co-founder of Global Spine Outreach. With Global Spine Outreach and other mission organizations, he performs surgery in European, South American and Ugandan cities. Dr. Siemionow holds multiple patents for devices and technologies that have been commercialized for use in nerve and spine surgery. He is theh founder of HoloSurgical, a digital surgery company, which performed the first in man surgery with its augmented reality and artificial intelligence system in January 2019. Further, he is co-founder of Dystrogen Therapeutics, a cell engineering company, which is developing chimeric cells for orphan diseases.

The Future of Digital Health and Wearables in Orthopedics
11:30 am – 12:15 pm

Orthopedic device companies have responded to payors’ adoption of bundled payments and FDA’s promotion of digital health tools by commercializing products that track patients beyond the O.R. Digital health tools, including wearables, provide device companies with revenue streams that respond to hospitals’ episode of care requirements and patients’ personalized medicine needs, while simultaneously creating a feedback loop for product ideas. Christopher E. Pelt, M.D., a surgeon enrolled in Zimmer Biomet’s mymobility clinical study with the Apple Watch app, offers perspective on the benefits of wearables and shares ways that the technology will impact patients, surgeons and device companies in the future.


  • Learn why and how surgeons seek wearable technology to track patients
  • Gain insight into ways that wearables and digital health will change the surgeon and patient experience five years from now

Christopher E. Pelt, M.D.,
specializes in hip and knee replacement and revision. He is a Tenured Associate Professor in the Department of Orthopaedics at the University of Utah, and serves as Medical Director of the Orthopaedic and Trauma Unit at the University Hospital, as well as Chief Value Officer for the inpatient orthopedic service line. His research interests center on patient outcomes and value following hip and knee reconstructive surgery. Dr. Pelt attended the University of Washington for his undergraduate education. He completed medical school at Creighton University, and his residency and advanced training in an adult reconstruction fellowship at the University of Utah Department of Orthopaedics.

The Future of Hospital/ASC Inventory Logistics
2:00 pm - 2:45 pm

Instrument innovation is a priority for orthopedic device companies that seek to meet surgeon and hospital requests to decrease inventory. Companies have introduced single-use instruments and fewer trays as part of the solution. Joe George, DPM, Director of the Foot and Ankle Practice at the Illinois Orthopedic Institute, recounts for attendees his O.R. and inventory logistic experiences with single-use and reusable instruments. Dr. George, a user of CrossRoads Extremity Systems' EcoSMART instrument recovery service, shares why he uses the program and why other companies should leverage a similar process. 


  • Understand why hospitals and ambulatory surgery centers seek supply chain efficiencies when it comes to instruments
  • Learn how surgeons are partnering with device companies to overcome implant and instrument inventory issues

Joe George, DPM,
serves as a podiatric surgeon at Illinois Orthopedic Institute. Dr. George completed a three-year podiatric medicine and surgical residency followed by a Foot & Ankle Reconstruction Fellowship. He has had extensive training both in the U.S. and Europe in foot and ankle trauma, as well as reconstruction. His extensive experience managing foot and ankle sports injuries and his dedication to his profession enable him to train other surgeons in conservative and surgical management of the foot and ankle. Dr. George is a fellow of the American College of Foot and Ankle Surgeons, American Society of Podiatric Surgeons, Illinois Podiatric Medical Association and the American Podiatric Medical Association. His published research and presentation topics include synovial folds in foot and ankle joints, functionality of the amputated limb and wound care considerations.

The Future of Orthobiologics in Trauma Procedures
3:15 pm - 4:00 pm


Based on his clinical research interests in utilization of Alpha-BSM bone graft substitute and OP-1 recombinant BMP in the repair of fractures, Daniel N. Segina, M.D., will outline opportunities and challenges for surgeons and device companies in biologic development. To make his case, Dr. Segina will review the spectrum of orthobiologics used in trauma cases today, share perspective on what is and isn’t working and forecast the future of regenerative medicine.


  • Appreciate the economic impact that orthobiologics represent in orthopedic trauma care
  • Understand the range of orthobiologics used in trauma cases
  • Learn the differentiation of the facts vs. the hype in orthobiologic clinical applications

Daniel N. Segina, M.D.,
is the Vice Chairman of the Department of Orthopedic Surgery at Holmes Regional Medical Center, and also Orthopaedic Surgery Service Line Medical Director at Health First Inc. in Melbourne, Florida. Additionally, Dr. Segina is an Assistant Professor at the University of Central Florida College of Medicine. Dr. Segina received his B.A. in Genetics from the University of California, Berkeley. He earned his Doctor in Medicine from the University of California, Irvine. He completed his residency in Orthopaedic Surgery at The Ohio State University, and is also fellowship trained in orthopedic trauma, completed at Harborview Medical Center in Seattle, Washington. Dr. Segina has co-authored numerous peer-reviewed articles and book chapters. He has lectured extensively on various topics related to orthopedic surgery and fracture care in the U.S. and internationally.

Thursday, June 13

The Future of Advanced Materials in Spine Surgery
10:00 am – 10:45 am

Orthopedics has maximized its use of cobalt-chrome, titanium and stainless steel, argues Kornelis Poelstra, M.D., Ph.D. His perspective complements industry discussions suggesting that the next wave of orthopedic and spine innovation will come from materials. Dr. Poelstra, who has encouraged FDA to be more accepting of new materials, outlines his thoughts on why industry must pursue new materials, such as Molybdenum-Rhenium (MoRe), that he believes will gain greater acceptance in orthopedics and spine.


  • Learn how surgeons prioritize materials when deciding to use a new device
  • Hear why one surgeon believes that MoRe and other materials will see increased adoption in spine

Kornelis Poelstra, M.D., Ph.D.,
is a spine surgeon specializing in long-construct minimally invasive surgery, adult deformity, revision and oncologic conditions, fracture treatment and cervical disc replacement. He is a world leader in robotic surgery and has performed more than 700 complex robotic cases. He has an extensive research background in implant-associated wound infections, novel material sciences for spine and orthopedic implant designs, and has worked on stem cell implantation for spinal cord injury. The mechanical and cellular processes salient for the formation of a stable arthrodesis and implant incorporation into the human body interest him. Dr. Poelstra holds orthopedic and spine surgery training certificates and received a Ph.D. in Biomedical Engineering from the University of Groningen in The Netherlands. He is the Founder and Director of the Spine Center of Excellence at Sacred Heart Hospital in Northwest Florida.

The Future of Personalized Implants in Joint Replacement: Additive, Robotics, Augmented Reality
11:15 am – 12:00 pm


Orthopedics is primed for mass customization of implants thanks to advancements in additive, AI and robotics. Fully leveraged, the technologies can produce patient-specific implants that achieve clinical benefit, decrease cost and maintain O.R. workflow. Founder and Chief Medical Officer of Monogram Orthopaedics, Douglas Unis, M.D., shares his reimagined vision of personalized joint replacement implants and just-in-time inventory solutions.


  • Gain insight into the current limitations of personalized, patient-specific joint replacement
  • Understand how other technologies—AI, robotics and additive—will support greater adoption of patient-specific implants
  • Learn one surgeon's perspective on how to scale personalized implants

Douglas Unis, M.D., is an orthopedic surgeon specializing in hip and knee replacement, with affiliations at Mount Sinai hospitals. He has extensive experience in the muscle- and tendon-sparing anterior hip replacement technique, and was among the first to perform the procedure in New York City in 2006. Dr. Unis actively participates in clinical research related to hip and knee reconstruction, including anatomic knee alignment, 3D printing of implants and robotics. As Founder and Chief Medical Officer of Monogram Orthopaedics, he is leading a team that intends to disrupt the industry with a just-in-time, clinically superior solution that cost-efficiently normalizes patient outcomes. He received his doctorate in medicine from Case Western Reserve University School of Medicine.